In a groundbreaking move, Nigeria has initiated a nationwide HPV vaccination campaign aimed at safeguarding the health of 7.7 million young girls. This historic effort aims to combat cervical cancer, the third most common cancer in Nigeria and a significant cause of cancer-related deaths among women aged 15 to 44.
Cervical cancer has long cast a shadow over the lives of Nigerian women, with the country reporting a staggering 12,000 new cases and 8,000 deaths from the disease in 2020 alone. However, this vaccination drive is a ray of hope, offering a powerful means of prevention.
The Coordinating Minister of Health & Social Welfare, Muhammad Ali Pate, emphasized the urgency of this initiative, stating, “The loss of about 8,000 Nigerian women yearly from a disease that is preventable is completely unacceptable.” Cervical cancer is primarily caused by the Human Papillomavirus (HPV), and this vaccination presents an opportunity to protect young girls from its devastating impact.
The campaign is aligned with President Bola Ahmed Tinubu’s Renewed Health Agenda, which places saving lives and promoting the well-being of Nigerians at its core. By introducing HPV vaccination, Nigeria is taking a significant step toward securing a healthier future for its citizens.
The vaccination campaign will commence with a five-day mass drive in schools and communities across 16 states and the Federal Capital Territory. Following this initial rollout, the vaccine will be incorporated into routine immunization schedules within health facilities. The second phase, scheduled for May 2024, will extend the initiative to 21 states.
Crucially, the HPV vaccine is being provided free of charge by the Federal Ministry of Health, thanks to support from Gavi, the Vaccine Alliance, UNICEF, the World Health Organization (WHO), and other partners. Over 35,000 health workers have been trained to ensure the success of the campaign, and vaccination sites have been established in all 4163 wards across the first 16 states to ensure that no eligible girl is left behind. Mobile vaccination units have been deployed to reach even remote communities.
Dr. Walter Kazadi Mulombo, WHO Representative in Nigeria, hailed this as a pivotal moment in the country’s fight against cervical cancer, a disease that could potentially be eliminated through vaccination. He reaffirmed WHO’s commitment to supporting the government’s efforts in increasing HPV vaccine access.
The introduction of the HPV vaccine in Nigeria is part of a broader global effort to combat cervical cancer. Recognizing the importance of this, Gavi recently approved an investment of over US$600 million by the end of 2025 to revitalize its HPV vaccine program, with the goal of reaching over 86 million girls worldwide. This initiative aims to prevent over 1.4 million future deaths from cervical cancer.
Thabani Maphosa, Managing Director of Country Programmes Delivery at Gavi, stressed the importance of this vaccine in preventing a disease that has profound effects on families and disproportionately impacts women. He emphasized that with the vaccine now available, Nigeria has a significant opportunity to save millions of lives.
UNICEF, which has procured nearly 15 million HPV vaccines for Nigeria, is playing a crucial role in dispelling misinformation and ensuring that eligible girls have access to the vaccine. They have also conducted readiness assessments and provided logistical support for vaccination campaigns.
In closing, the introduction of the HPV vaccine in Nigeria is a monumental step toward a brighter and healthier future for its young women. It represents a powerful tool in the fight against cervical cancer, offering hope, resilience, and the promise of a disease-free life.
Source: [Vanguard]
